Urigrow-D 0.4/0.5 Tablet is a combination drug containing 'urinary bladder relaxant' medication, used primarily in treating the enlarged prostate gland. Benign prostatic hyperplasia (enlarged prostate gland) is a non-cancerous growth of the prostate gland caused due to overproduction of a dihydrotestosterone hormone in men. As the gland enlarges, it can lead to urinary problems, such as difficulty passing urine and frequent urination. Urigrow-D 0.4/0.5 Tablet helps in getting relief from these symptoms. And also, Urigrow-D 0.4/0.5 Tablet does not cure prostate cancer.

Urigrow-D 0.4/0.5 Tablet contains Tamsulosin (alpha-blockers) and Dutasteride (5-alpha reductase inhibitor), primarily used to treat enlarged prostate glands. Tamsulosin makes it easy to pass urine by relaxing the muscles of the prostate gland. On the other hand, Dutasteride reduces the enlarged prostate gland's size by lowering the production of dihydrotestosterone hormone, thereby relieving the symptoms of urinary incontinence that minimizing the need for prostate surgery and the risk of acute urinary retention. Collectively, both of them improve the symptoms of Benign Hyperplasia Prostate (BPH).

Take Urigrow-D 0.4/0.5 Tablet as prescribed by your doctor. You are advised to take Urigrow-D 0.4/0.5 Tablet for as long as your doctor has prescribed it for you, depending upon your medical condition. The most common side effects of Urigrow-D 0.4/0.5 Tablet are dizziness, lightheadedness, drowsiness, sexual problems (decreased sex drive or libido), runny/stuffy nose, reduced amount of semen/sperm), testicle pain/swelling, increased breast size, or breast tenderness. They do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor. 

Women or children should not take $ name. Please inform your doctor before starting Urigrow-D 0.4/0.5 Tablet have low blood pressure, liver/kidney disease, history of heart problems. It is advisable to wear a male contraceptive (like a condom) while having sex if your wife is pregnant as Urigrow-D 0.4/0.5 Tablet is known to pass in semen. Do not donate blood while taking Urigrow-D 0.4/0.5 Tablet . However, you can donate it after six months after you take the last dose of Urigrow-D 0.4/0.5 Tablet .

Urigrow-D 0.4/0.5 Tablet contains tamsulosin (alpha-blockers) and dutasteride (5-alpha reductase inhibitor), primarily in treating the enlarged prostate gland. As the gland enlarges, it can lead to urinary problems, such as difficulty passing urine and a frequent urination urge. Dutasteride lowers the production of dihydrotestosterone hormone, which leads to a decrease in the size of the prostate and, as a result, relieves the symptoms. This will reduce the risk of acute urinary retention and the need for surgery. Tamsulosin makes it easy to pass urine by relaxing the muscles of the gland. Collectively, both of them improve the symptoms of Benign Hyperplasia Prostate (BPH).

• Impotence (not able to achieve or maintain an erection)

• Decreased sex drive (libido)

• Difficulty with ejaculation 

• Gynecomastia (breast enlargement or tenderness)

• Dizziness

Do not take Urigrow-D 0.4/0.5 Tablet if you are allergic to Urigrow-D 0.4/0.5 Tablet or any of the ingredients. Urigrow-D 0.4/0.5 Tablet should not be taken if you have low blood pressure, which makes you feel dizzy, lightheaded or faint, glaucoma. And also, Urigrow-D 0.4/0.5 Tablet should be taken 30 minutes after a meal. Inform your doctor if you have a history of heart disease, liver/kidney disease. Before undergoing surgery (cataract), please consult a doctor as you might be advised to stop Urigrow-D 0.4/0.5 Tablet .  During sexual intercourse, use a condom as Urigrow-D 0.4/0.5 Tablet is found in semen. Contact your doctor for advice if you are pregnant or plan to get pregnant before taking Urigrow-D 0.4/0.5 Tablet as it may affect the development of male genitals. Also, keep your doctor informed about all the OTC medicines you are using while taking Urigrow-D 0.4/0.5 Tablet . Patients taking Urigrow-D 0.4/0.5 Tablet should be cautioned about driving, operating machinery, or performing hazardous tasks as it can cause drowsiness or dizziness. In rare cases, problems of penis erection, ejaculation, and pain in the penis can occur. So if these symptoms are for a longer time, immediately contact your doctor.

Drug-Drug Interaction: Urigrow-D 0.4/0.5 Tablet is known to contra-indicate with medicines used to help achieve or maintain an erection (vardenafil, sildenafil, tadalafil), high blood pressure (verapamil, diltiazem), antidepressants (fluoxetine, paroxetine), anti-HIV (ritonavir, indinavir), blood thinners (warfarin), antibiotics (erythromycin), NSAIDs (diclofenac, ibuprofen, indomethacin).

Drug-Food Interaction: Urigrow-D 0.4/0.5 Tablet is known to interact when taken along with alcohol and St John’s Wort (a natural remedy to treat depression). Also, keep your doctor informed about all the OTC medicines you are using while taking Urigrow-D 0.4/0.5 Tablet .

Drug-Disease Interaction: Urigrow-D 0.4/0.5 Tablet should not be given to the patients with eye problems (like glaucoma or cataract), liver/kidney disease, hypotension (low blood pressure).

• VARDENAFIL
• SILDENAFIL
• TADALAFIL
• VERAMAPIL
• DILTIAZEM
• FLUOXETINE
• PAROXETINE
• RITONAVIR
• INDINAVIR
• WARFARIN
• ERYTHROMYCIN
• DICLOFENAC
• IBUPROFEN
• INDOMETHACIN

• Avoid drinking less alcohol, caffeine, and fizzy drink. Limit intake of artificial sweeteners.

• Maintain a healthy lifestyle and exercise regularly so that you do not feel heavy in the abdomen region.

• Also, drink less water in the evening and before sleeping to have a sound sleep and do not wake up frequently for urination.

• Any medication which may worsen urinary symptoms (medication for cold and cough) should be avoided.

• Consult your doctor immediately if you have symptoms such as shortness of breath, extreme tiredness, and swelling in your ankles and legs.

• Urigrow-D 0.4/0.5 Tablet is not intended for use as an antihypertensive (blood pressure lowering) drug.

• Don't stand suddenly from a lying or resting position, which may increase the risk of falls.

Benign prostatic hyperplasia (BPH): Benign prostatic hyperplasia is the enlargement of the prostate gland. It is a non-cancerous growth of the prostate gland caused due to overproduction of dihydrotestosterone hormone in men. If not treated, it may lead to the formation of bladder stone, infection, and reduced kidney function. BPH usually occurs in the male who is above 50 years of age.